Goldman Sachs’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Buy |
720,681
+375,915
| +109% | +$11.9M | ﹤0.01% | 1681 |
|
|
2025
Q1 | $11.4M | Sell |
344,766
-150,282
| -30% | -$4.99M | ﹤0.01% | 2123 |
|
|
2024
Q4 | $17M | Buy |
495,048
+187,035
| +61% | +$6.44M | ﹤0.01% | 1917 |
|
|
2024
Q3 | $12.3M | Sell |
308,013
-147,351
| -32% | -$5.89M | ﹤0.01% | 2095 |
|
|
2024
Q2 | $13.7M | Buy |
455,364
+244,410
| +116% | +$7.37M | ﹤0.01% | 1853 |
|
|
2024
Q1 | $7.08M | Sell |
210,954
-60,146
| -22% | -$2.02M | ﹤0.01% | 2318 |
|
|
2023
Q4 | $8.76M | Buy |
271,100
+69,142
| +34% | +$2.23M | ﹤0.01% | 2191 |
|
|
2023
Q3 | $6.62M | Sell |
201,958
-115,045
| -36% | -$3.77M | ﹤0.01% | 2275 |
|
|
2023
Q2 | $11.2M | Sell |
317,003
-11,331
| -3% | -$399K | ﹤0.01% | 1949 |
|
|
2023
Q1 | $10.7M | Buy |
328,334
+219,310
| +201% | +$7.16M | ﹤0.01% | 1959 |
|
|
2022
Q4 | $6.01M | Sell |
109,024
-56,587
| -34% | -$3.12M | ﹤0.01% | 2486 |
|
|
2022
Q3 | $7.34M | Buy |
165,611
+97,334
| +143% | +$4.31M | ﹤0.01% | 2363 |
|
|
2022
Q2 | $3.33M | Buy |
68,277
+4,618
| +7% | +$225K | ﹤0.01% | 3022 |
|
|
2022
Q1 | $3.1M | Buy |
63,659
+16,753
| +36% | +$815K | ﹤0.01% | 3209 |
|
|
2021
Q4 | $2M | Sell |
46,906
-7,610
| -14% | -$324K | ﹤0.01% | 3497 |
|
|
2021
Q3 | $2.09M | Buy |
54,516
+25,955
| +91% | +$995K | ﹤0.01% | 3456 |
|
|
2021
Q2 | $806K | Buy |
28,561
+14,741
| +107% | +$416K | ﹤0.01% | 4156 |
|
|
2021
Q1 | $457K | Buy |
13,820
+4,935
| +56% | +$163K | ﹤0.01% | 4425 |
|
|
2020
Q4 | $321K | Sell |
8,885
-29,178
| -77% | -$1.05M | ﹤0.01% | 4048 |
|
|
2020
Q3 | $1.29M | Buy |
+38,063
| New | +$1.29M | ﹤0.01% | 3163 |
|